RNAi Meets Microarrays: Uses Range from Sequence Selection to SARS Drugs | GenomeWeb

It seems like one of those fated celebrity pairings: the still-simmering microarray meets RNAi, the new darling of functional genomics, and the RNAi microarray is born. But the reality is still in the experimental stages, and it’s not yet clear how this marriage will turn out.

RNAi, or RNA interference, involves transfecting a cell with a double-stranded sequence of RNA, triggering a process that silences expression of corresponding genes in the cell. RNAi works one gene and one cell at a time, but RNAi microarrays promise to make these assays high-throughput.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.